Screener
Nutex Health Inc. NUTX Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Nutex Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Nutex Health Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054268
FAQ
- What is Nutex Health Inc.'s cash & equivalents?
- Nutex Health Inc. (NUTX) reported cash & equivalents of $207.11M in Q2 2026.
- How has Nutex Health Inc.'s cash & equivalents changed year-over-year?
- Nutex Health Inc.'s cash & equivalents increased by 114.1% year-over-year, from $96.73M to $207.11M.
- What is the long-term trend for Nutex Health Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Nutex Health Inc.'s cash & equivalents has grown at a 485.9% compound annual growth rate (CAGR), from $26.93K to $185.87M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Nutex Health Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude